Resources

COVID-19 is sparking new demands on Ontario health system leaders – and the surge of need is bigger than traditional communications can carry. There is risk in duplication and gaps in expertise. REAL Resources is our way of curating the disparate information sources reviewed in the development of REAL Notes, and those submitted by others adding to our body of knowledge.

REAL Resources is a common ground for decision makers to find what is working and to see how it works in practice.

Resource Title	Details	Published Ascending Descending
Treatments — BCCDC: British Columbia Centre for Disease Control	Type: Professional Organization Guidance Tags: Patient Care, Symptoms, Treatments	September 20, 2020
Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19 (FIGHT-COVID-19) — Kongsaengdao et al.	Type: Single Study Tags: Influenza, Patient Care, Symptoms, Treatments	August 31, 2020
More about chloroquine and hydroxychloroquine — CEBM: The Centre for Evidence-Based Medicine	Type: Evidence Syntheses Tags: Patient Care, Symptoms, Treatments	August 29, 2020
IMU-838 and Oseltamivir in the Treatment of COVID-19 (IONIC) — Arasaradnam et al.	Type: Single Study Tags: Influenza, Patient Care, Symptoms, Treatments	August 20, 2020

Resources

Filters Close

Treatments — BCCDC: British Columbia Centre for Disease Control

Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19 (FIGHT-COVID-19) — Kongsaengdao et al.

More about chloroquine and hydroxychloroquine — CEBM: The Centre for Evidence-Based Medicine

IMU-838 and Oseltamivir in the Treatment of COVID-19 (IONIC) — Arasaradnam et al.

Filters